2/11/2025 3:50:42 PM Medical Devices in the UK: Changes to Post-Market Surveillance By Sophie Vo Quinn Liang On 11 December 2024, the MHRA published an updated roadmap for the future of the regulatory framework for medical devices in the UK,...
2/11/2025 8:39:19 AM Strengthening Pharma IP: China’s Boost to Data and Market Exclusivity By Alison Wong * This article was co-authored with Olivia Zhao from Bird & Bird Lawjay Shanghai association team. On 3 January 2025, the General Office...
1/29/2025 11:15:40 AM First decision on the SPC manufacturing waiver by the Belgian courts By Domien Op de Beeck Camille Vanpeteghem On 23 December 2024, the Brussels enterprise court issued a first decision in Belgium on the so-called “SPC manufacturing waiver”. Under...
12/16/2024 1:59:46 PM Australian Extensions of Patent Term continue for "mixture" formulations By Jane Owen The Federal Court of Australia has confirmed that an extension of patent term for Novo Nordisk's patent claiming liraglutide plus...
11/13/2024 1:39:46 PM M&A in Life Sciences By James Baillieu Companies in the life sciences sector and its sub-sectors, including pharmaceuticals, medical devices, diagnostics and services, are...
7/18/2022 5:49:00 PM Final(ly) Rules of Procedure of the UPC By Christopher de Mauny Domien Op de Beeck Apart from the Unified Patent Court Agreement and a large body of further treaties, regulations, directives and laws governing the...